Carvykti’s Q1 2025 sales reached $369 million, exceeding consensus estimates by approximately 5% and showing quarter-over-quarter growth of over 10%. This performance has contributed to Legend Biotech …
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition
view original post